下丘脑SF1神经元通过交感神经调控肺神经气道相关巨噬细胞NF-κB信号通路在急性肺损伤中的作用研究
批准号:
82100098
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
张佳
依托单位:
学科分类:
急性肺损伤和急性呼吸窘迫综合征
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
张佳
中文摘要
ALI/ARDS是临床常见危重症,严重威胁患者生命。预实验显示SF1神经元在ALI动物模型中异常活化;激活SF1神经元可在ALI模型中上调肺内NF-κB信号和血TNF-α水平,活化肺交感神经。这提示SF1神经元可能通过交感神经发挥神经免疫调节作用,并参与ALI的发生发展,有可能为治疗ALI/ARDS另辟蹊径。肺内神经气道相关巨噬细胞(NAMs)与交感神经关系密切,并高度表达免疫调节基因。本研究认为NAMs有可能是SF1神经元-交感神经-肺巨噬细胞调控通路的肺内靶细胞。为此拟进一步考察肺交感神经活性抑制状态下,正反两方面调控SF1神经元活性对ALI模型和交感神经的影响,证明SF1神经元对ALI和交感神经的作用,以及探索其可能作用的肺内巨噬细胞亚型。预期结果可能证明SF1-交感神经-NAMs神经免疫调控通路的存在及其在ALI中的调控作用,为ALI/ARDS的新机制和新靶点开发提供证据。
英文摘要
Clinically, ALI/ARDS is a common but devastatingly critical disease that seriously threatens the patients’ lives. Previous research shows that hypothalamic SF1 neurons are abnormally activated in the mice model of ALI, Precisely targeted activation of SF1 neurons through chemical genetic methods give rise to activation of lung sympathetic nerve as well as elevated inflammatory responses both in the lungs (NF-κB signaling) and in the peripheral blood (TNF-α) in the animal model of ALI. All these data indicate that SF1 neurons may exert their neuro-immunoregulatory functions through the sympathetic nerve and thus play a role in the pathogenesis of ALI, hence may provide a special but promising direction for overcoming ALI/ARDS. Pulmonary nerve airway associated macrophages (NAMs) are resided closely related to sympathetic nerves and can express high levels of immunoregulatory genes. We postulate that NAM may present as the key target effector cells participating the regulatory pathway of SF1 neuron-symphathetic nerve-lung macrophages. We designed the current study to further explore the impacts of SF1 activation or inhibition on ALI and the sympathetic nerve in case of sympathetic nerve deletion, so as to prove the role of SF1 on ALI and lung sympathetic fibers and the subtype effector cells of lung macrophages. The results may provide evidence to support the existence of SF1-symphathetic nerve-NAM neuroimmunoregulatory axis and its regulation on ALI, to provide evidences for elucidating new mechanisms and novel drug targets in ALI/ARDS.
急性肺损伤/急性呼吸窘迫综合征(ALI/ARDS)是一种常见危重症,病死率极高,治疗措施有限,部分患者发生炎症后纤维化,严重影响患者生活质量及预后。探索新的治疗措施显得尤为重要,近年来发现神经免疫调节在炎症过程发挥重要的作用,但具体机制不明。研究发现ALI模型小鼠下丘脑脑区神经元明显活化,急性肺损伤小鼠SF1神经元会激活肺内NF-κB信号通路,加重肺损伤。利用脂多糖诱导急性肺损伤模型、博来霉素诱导的肺损伤(肺纤维化)模型及神经毒素6羟基多巴胺去除肺内交感神经模型,通过化学遗传学、光遗传学、实时光纤测光电生理记录来检测及调控下丘脑相关神经元,进一步利用免疫染色、Western Blotting(WB),ELISA,RT-qPCR等检测手段检测外周脏器交感神经及肺组织中相关炎症及纤维化指标的变化,并利用全转录组学、蛋白质组学,在目前项目的基础上进一步拓宽了研究范围,探索下丘脑SF1神经元-交感神经-外周脏器免疫调节途径对肺损伤,炎症后纤维化进行研究,为靶向神经-肺免疫治疗ALI和肺纤维化探索新的靶点,提供理论依据。
国内基金
海外基金